Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avandamet Approved as Initial Diabetes Treatment | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Avandamet Approved as Initial Diabetes Treatment

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline received approval from the FDA for Avandamet for use as initial treatment of type 2 diabetes, as an adjunct to diet and exercise. Avandamet was previously approved as a second-line therapy for use in patients who were uncontrolled on metformin monotherapy. With this recent approval, physicians can start their type 2 diabetes patients on Avandamet. The approval for Avandamet coincides with the company’s announcement that its supply of the drug has been re-established.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters